H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-08-03,CFO,BLOCH KATHLEEN P. ,期权,10000普通股, $2.88
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-08-02,COO,Capponi Vincent ,卖出,2835普通股, $13.00
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-08-03,COO,Capponi Vincent ,卖出,7600普通股, $13.08
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-08-03,COO,Capponi Vincent ,期权,7600普通股, $3.45
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-08-02,COO,Capponi Vincent ,期权,2835普通股, $3.45
$Cytosorbents Corporation(CTSO)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2018-08-03 AccNo: 0001144204-18-041955 Size: 672 KB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-08-03 AccNo: 0001144204-18-041930 Size: 168 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001144204-18-041671 Size: 6 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001144204-18-041671 Size: 6 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2018-08-02 盘后 披露财报,预期EPS -0.13 网页链接